🇺🇸 Ramipril + Felodipine in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Appendicitis Perforated — 1 report (10%)
2. Blood Pressure Increased — 1 report (10%)
3. Confusional State — 1 report (10%)
4. Constipation — 1 report (10%)
5. Cough — 1 report (10%)
6. Dehydration — 1 report (10%)
7. Diarrhoea — 1 report (10%)
8. Dyspnoea — 1 report (10%)
9. Fall — 1 report (10%)
10. Gastritis — 1 report (10%)

Source database →

Frequently asked questions

Is Ramipril + Felodipine approved in United States?

Ramipril + Felodipine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ramipril + Felodipine in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.